Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study

BACKGROUND: Since 2007 biosimilars of erythropoiesis-stimulating agents (ESAs) are available on the Italian market. Very limited post-marketing data exist on the comparative effectiveness of biosimilar and originator ESAs. AIM: This population-based study was aimed to compare the effects of biosimil...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingrasciotta, Ylenia, Giorgianni, Francesco, Marcianò, Ilaria, Bolcato, Jenny, Pirolo, Roberta, Chinellato, Alessandro, Ientile, Valentina, Santoro, Domenico, Genazzani, Armando A., Alibrandi, Angela, Fontana, Andrea, Caputi, Achille P., Trifirò, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871488/
https://www.ncbi.nlm.nih.gov/pubmed/27187174
http://dx.doi.org/10.1371/journal.pone.0155805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871488/
https://www.ncbi.nlm.nih.gov/pubmed/27187174
http://dx.doi.org/10.1371/journal.pone.0155805

Ejemplares similares